ALIGNMENT HEALTHCARE, INC. Net Change in Cash
ALIGNMENT HEALTHCARE, INC. (ALHC) reported Net Change in Cash of $117.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-07-30
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $129.78M, a 873.19% increase year-over-year.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $13.34M, a 63.09% decline year-over-year.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $36.13M.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$25.29M.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $142.99M, a 37.83% decline from fiscal 2024.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $229.99M.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$206.34M.
- ALIGNMENT HEALTHCARE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$57.05M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $117.65M 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | $129.78M 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $142.99M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $185.24M 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | $37.42M 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | $13.34M 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | $229.99M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $137.75M 10-Q · filed 2025-10-30 | |||
| 2024-06-30 | $136.12M 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | $36.13M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$206.34M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | -$17.91M 10-Q · filed 2024-10-29 | |||
| 2023-06-30 | -$14.29M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | -$25.29M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$57.05M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |